Postpartum haemorrhage (PPH) remains a critical reason to prioritize maternity pads in global wholesale purchasing.
The World Health Organization reports that haemorrhage caused about 27% of maternal deaths worldwide between 2000 and 2020.
This figure appears in Trends in Maternal Mortality 2000 to 2020, published by WHO, UNICEF, UNFPA, World Bank Group, and UNDESA.
A maternity pad cannot stop bleeding. However, it can support early observation when blood loss appears heavier than expected.
In a busy maternity ward, staff may need to assess a pad within minutes, not hours. A suitable product should offer reliable absorbency, a secure shape, soft surface materials, and packaging that protects hygiene during transport.
Buyers should also examine leakage control, sizing, disposal instructions, and performance evidence from the supplier. WHO’s Roadmap to Combat Postpartum Haemorrhage 2023–2030 stresses timely recognition and treatment. Product design should support that clinical reality, not distract from it.
Wholesale decisions need more than attractive specifications. Regional climate, storage conditions, birth settings, and local care practices can change performance.
A very absorbent pad may still feel bulky or reduce patient comfort. This is an easy detail to overlook.
Buyers should request test methods, production controls, and transparent quality records before placing large orders. Exact needs differ between hospitals, clinics, and community settings.